Current Health

What Current Health does

Current Health is a Boston-headquartered (with engineering in Edinburgh) digital health company that provides an AI-enabled remote patient monitoring platform for delivering high-acuity care and advanced therapies (CAR-T and bispecific antibodies) in outpatient and home settings. Its core technology combines an FDA Class II 510(k)-cleared proprietary upper-arm wearable that passively tracks five vital signs with machine learning algorithms validated in a JCI Insight publication to detect cytokine release syndrome a median of 7 hours earlier than standard of care. The platform is supported by a 24/7 Clinical Command Center staffed by ED- and ICU-trained nurses licensed in all 50 states, bi-directional integration with Epic, Cerner, and Meditech, and a care operations layer that automates scheduling, route planning, and logistics.

The company serves three primary customer segments: large health systems and academic medical centers running hospital-at-home and outpatient advanced therapy programs (e.g., Mass General Brigham, Sarah Cannon/HCA, MSK, Mount Sinai, UCSF, Vanderbilt, OSF HealthCare, Baptist Health, Advocate Health, HealthFirst, Virtua, UMass Memorial); life sciences companies such as Bristol Myers Squibb that need pharmacovigilance, decentralized trial infrastructure, and RWE generation across Phase I-IV trials; and community oncology practices, physician groups, and MSOs that require turnkey infrastructure to administer CAR-T and bispecifics locally without FACT accreditation overhead. Notable clinical outcomes include 90%+ of CAR-T patients treated outpatient at Sarah Cannon, 25,000+ bed days saved at Mass General Brigham, and 89% of bispecific step-up doses successfully administered outpatient at MSK.

Current Health generates revenue through a combination of subscription-based access to the monitoring platform and FDA-cleared wearable, managed clinical services from the 24/7 Command Center, hardware sales or leases of monitoring kits, and professional services for life sciences clients. Pricing is quote-based and negotiated per enterprise program rather than publicly disclosed. The company was founded in Edinburgh in 2014, expanded to the United States in 2019, was acquired by Best Buy in 2021 for approximately $400 million, and was reacquired by its founders in 2025, who have refocused the business on advanced therapies as the primary growth driver and entered a 2026 partnership with Cardinal Health's Velocare for hospital-at-home logistics.

Name

Current Health

Legal name

Current Health, Inc.

Website

https://currenthealth.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Current Health provides an FDA-cleared AI-enabled remote patient monitoring platform and 24/7 clinical command center that enables health systems, academic medical centers, life sciences companies, and community oncology practices to safely deliver CAR-T, bispecific antibodies, and high-acuity care in outpatient and home settings.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Home Health Care Services (621610), Home Health Care Services (62161)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows) (HLALAFAH)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Remote patient monitoring
• Advanced therapy delivery
• Hospital-at-home programs
• AI clinical intelligence
• Continuous biometric monitoring

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Technology Platform Subscription: Subscription-based access to FDA-cleared monitoring platform, clinical dashboard, AI-enabled adverse event detection, and EHR integration. Includes proprietary wearable device and connected peripherals.
2. Clinical Services: 24/7 Clinical Command Center staffing by ED and ICU-trained nurses. Virtual ICANS assessments. Care coordination and operations support.
3. Hardware Sales: Sale or lease of proprietary wearable devices and connected peripheral devices (temperature patches, blood pressure cuffs, scales, etc.) included in patient monitoring kits.
4. Life Sciences / Clinical Trial Services: Pharmacovigilance infrastructure, decentralized trial enablement, RWE generation, and provider network services for pharma companies conducting Phase I-IV clinical trials on advanced therapies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Current Health provides an FDA-cleared, AI-enabled remote patient monitoring platform that combines a proprietary upper-arm wearable, passive biometric monitoring, machine learning-based adverse event detection (CRS, ICANS, sepsis), and a 24/7 Clinical Command Center staffed by ED/ICU-trained nurses. The platform is delivered to health systems, academic medical centers, community oncology practices, and life sciences companies to enable safe delivery of high-acuity care and advanced therapies (CAR-T, bispecifics) in outpatient and home settings.

Product overview

Current Health offers a unified platform combining FDA-cleared technology, AI-enabled clinical intelligence, and 24/7 nursing support for delivering complex care beyond the hospital. The portfolio centers on the Current Health wearable and Passive Remote Monitoring Platform with AI-Enabled Adverse Event Detection, supported by the 24/7 Clinical Command Center and Care Operations Platform. Service offerings span four models: High-Acuity Care at Home for hospital-at-home programs; Advanced Therapies for Health Systems and Community Clinics for outpatient CAR-T and bispecifics delivery; and Life Sciences for clinical trial enablement. All components integrate with major EHR systems (Epic, Cerner, Meditech) and are supported by Expert Consulting Services for program design and payer strategy.

Differentiator

Problem solved

Functional benefit

Products and services

• Current Health Platform (Passive Remote Monitoring Platform)
• Current Health Wearable
• Home Hub and Tablet Kit
• Connected Peripheral Device Packages
• 24/7 Clinical Command Center
• High-Acuity Care at Home Program
• Advanced Therapies Delivery Program
• Life Sciences Clinical Trial Enablement
• Expert Consulting Services
• Care Operations Platform

Quantifiable outcome

• 7 hours earlier CRS detection than standard of care, enabling proactive intervention
• +9 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core and flagship.

• Cardinal HealthcoreStrategic or Co-development Partner · 31 March 2026Cardinal Health's Velocare supply chain solution partnership for end-to-end logistics in hospital-at-home programs. Collaboration handles last-mile fulfillment, kit installation, and retrieval of Current Health's in-home clinical monitoring kits. Integrates platforms to streamline patient onboarding and reduce duplicate data entry. Partnership aims to help health systems simplify operations, lower program costs, and scale acute care-at-home programs sustainably.
• BMS (Bristol Myers Squibb)flagshipStrategic or Co-development PartnerStrategic partnership with BMS for outpatient advanced therapy delivery infrastructure. Partnered with leading manufacturers including BMS to move advanced therapies safely into outpatient and community settings. Early partnership in clinical development generates RWE supporting payer negotiations and enabling scaled community adoption.
• Sarah Cannon Cancer Institute (HCA Healthcare)flagshipStrategic or Co-development PartnerLaunched largest multisite outpatient CAR-T program in 2023. Sarah Cannon transitioned 90%+ of CAR-T therapies to outpatient setting using Current Health's platform. Saved 1,200+ bed days in first 100 cases. Leading research partnership with multiple peer-reviewed publications in Blood and other journals.
• Mass General BrighamflagshipStrategic or Co-development PartnerOne of nation's largest Hospital at Home programs demonstrating model scalability and clinical safety. Achieved 200% growth in 15 months, average daily census of 49 patients, 25K+ bed days saved. Joint case study and research publications documenting operational strategies and clinical outcomes.
• Memorial Sloan Kettering Cancer CentercoreStrategic or Co-development PartnerClinical research partnership on outpatient bispecific antibody delivery. 89% of patients successfully received step-up doses of Teclistamab and Talquetamab at outpatient setting. Research published in ASH Blood Advances demonstrating safety of outpatient step-up dosing protocols.
• Mount SinaicoreStrategic or Co-development PartnerClinical research collaboration on wearable monitoring for outpatient CAR-T. Prospective trial published in JCI Insight showing 7-hour median lead time for CRS detection vs. standard nursing care. Validates Current Health platform's early detection capabilities.
• UCSF HealthcoreStrategic or Co-development PartnerPartnership for migrating advanced therapies to outpatient settings. Joint webinar on operational insights for outpatient CAR-T and bispecific pathways. Clinical leaders sharing experience on program building, patient flow, and provider engagement.

Scale indicators16 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Cadence: Hospital-at-home technology and care model provider partnering with large health systems to deliver acute care at home. Directly competes for the same HaH RFPs that Mass General Brigham, Advocate, and other Current Health customers represent.
• VitalConnect: Provider of a clinical-grade wearable biosensor (VitalPatch) and RPM platform used for hospital-at-home and ambulatory monitoring. Competes head-to-head with Current Health's proprietary wearable for continuous multi-vital monitoring in post-acute and acute care at home.
• Biofourmis: Boston-based AI-enabled RPM and hospital-at-home platform with FDA-cleared algorithms. Targets similar health-system customers and shares the playbook of combining wearable monitoring, predictive analytics, and care coordination - the closest direct competitor to Current Health.
• Vivify Health (Optum / UnitedHealth Group): Pioneer in RPM and connected health platforms, now part of Optum. Competes in chronic and post-acute RPM with enterprise health system deployments analogous to Current Health's customer base.
• Health Recovery Solutions (HRS): RPM and patient engagement platform deployed across hundreds of US health systems for chronic care and post-acute management. Overlaps with Current Health on hospital-at-home programs and chronic-disease monitoring use cases.

Emerging players

• Medable: Decentralized clinical trial platform partnered with pharma sponsors for remote monitoring and eCOA/ePRO. Overlaps with Current Health's Life Sciences/clinical-trial business line for pharma trial infrastructure.

Broad incumbents

• Masimo: Public patient monitoring company with FDA-cleared wearable sensors (e.g., MightySat, Radius PPG) and continuous monitoring offerings. A broader incumbent moving into ambulatory, hospital, and home monitoring - an adjacent threat in the clinical-grade wearable space.
• Medtronic (Cardiac Diagnostics / LINQ family): Large device manufacturer with cardiac remote monitoring (LINQ, CareLink) serving millions of patients. Has the regulatory, manufacturing, and hospital relationships to expand into general RPM and compete with Current Health for cardiology-adjacent and general ward telemetry use cases.
• Philips (HealthSuite / RPM): Diversified medtech incumbent with RPM, hospital telehealth, and care-at-home solutions across its HealthSuite platform. Competes broadly in health-system RPM purchases, though not as specialized in advanced-therapy delivery.
• GE Healthcare: Major imaging and patient monitoring vendor increasingly bundling RPM and command-center capabilities. Targets the same acute-care-at-home and centralized monitoring RFPs as Current Health's Clinical Command Center.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@current_health
• LinkedInlinkedin.com/company/currenthealth
• Xx.com/HeyCurrent
• Facebookfacebook.com/HeyCurrentHealth

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds11 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Current Health